Acrospire Investment Management’s QIAGEN NV QGENF Stock Holding History

Acrospire Investment Management’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-5,600	Closed	-$157K	–	2752
2016 Q4	$157K	Buy	5,600 +2,500	+81%	+$70.1K	0.06%	566
2016 Q3	$85K	Sell	3,100 -1,200	-28%	-$32.9K	0.06%	683
2016 Q2	$94K	Buy	4,300 +600	+16%	+$13.1K	0.07%	513
2016 Q1	$83K	Buy	+3,700	New	+$83K	0.06%	468

Other funds holding QGENF

BJCM

Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return

Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Acrospire Investment Management's QGENF Position: Q1 2017 in Review

Acrospire Investment Management sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 5,600 shares — an estimated $157K sold.

Acrospire Investment Management first reported a position in QGENF in Q1 2016 and held it in 4 quarters. The position peaked at $157K in Q4 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

Acrospire Investment Management reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
Acrospire Investment Management sold 5,600 QIAGEN NV shares in Q1 2017, an estimated $157K.
Acrospire Investment Management first reported a position in QIAGEN NV in Q1 2016 and held it in 4 quarters.
Acrospire Investment Management's QIAGEN NV position peaked at $157K in Q4 2016.
6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Acrospire Investment Management's 13F filing for Q1 2017, filed 4 May 2017.